Anabolic Steroids Market Analysis

  • Report ID: 5986
  • Published Date: May 10, 2025
  • Report Format: PDF, PPT

Anabolic Steroids Segmentation

Modes of Administration (Oral, Injection, Topical, Skin Patches, Inhalers)

Based modes of administration, injection segment in the anabolic steroids market is anticipated to hold 45% of the revenue share by 2037. The injections segment is being driven by a number of factors, including high unmet demand, an increase in the frequency of bone & joint problems, government awareness programs for joint disorders, a rise in the number of obese people as a result of unhealthy lifestyles, and favorable health insurance coverage. Globally, the Statistic Brain Research Institute estimates that 50 million people have been diagnosed with arthritis. The global market for steroid injections is also being driven by factors such as growing demand for steroid injections, improvements in steroid injection treatment, and growing health consciousness. About 180 million people in India suffer from arthritis, according to Arthritis-India. The prevalence of many well-known illnesses is higher than this, including cancer, AIDS, and diabetes. With more than 60 million people predicted to be impacted, India is predicted to become the global epicenter for osteoarthritis by 2025. Owing to the quick and efficient results, there is a growing demand for steroid injections, which is driving this anabolic steroids market expansion.

Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Based on distribution channels, online pharmacies segment in the anabolic steroids market is anticipated to hold 40% of the revenue share by 2037. Online sales are expected to rise since manufacturers and distributors are currently leaning toward doing business online. Furthermore, the anabolic steroids market is driven higher by the growing usage of smartphones and the widespread use of social media. Global mobile user count was 7.1 billion in 2021; predictions indicate that by 2022, this figure is expected to increase to 7.26 billion. Global mobile user count is expected to reach 7.49 billion by 2025.

Our in-depth analysis of the global market includes the following segments:

         Synthetic Derivatives

  • 17 Alpha Alkyl Derivatives

  • 17 Beta Ester Derivatives

          Modes of Administration

  • Oral

  • Injection

  • Topical

  • Skin Patches

  • Inhalers

          Indication

  • Anaemia

  • Breast Cancer

  • Hypogonadism

          Drugs

  • Oxymetholone

  • Methyltestosterone

  • Testosterone

          Type

  • Prescription Drugs

  • Over-The-Counter Drugs

          Applications

  • Anabolic

  • Androgenic

          Distribution Channels

  • Hospital Pharmacies

  • Retail Pharmacies

  • Online Pharmacies

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

Anabolic Steroids Market in 2025 is evaluated at USD 17.75 billion.

The global market size was more than USD 16.42 billion in 2024 and is anticipated to grow at a CAGR of over 10.1%, reaching USD 57.36 billion revenue by 2037.

North America is estimated to collect USD 18.93 billion by 2037, due to rising breast cancer incidence and healthcare spend.

The major players in the market include Mylan N.V., F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Johnson & Johnson Private Limited, Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd., Merck & Co., Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos